Skip to content

Compliance With Dietary Recommendations in Children at Risk for Undernutrition

Compliance With Dietary Recommendations in Meeting Nutritional Requirements in Children at Risk of Undernutrition

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01658267
Enrollment
200
Registered
2012-08-07
Start date
2011-10-31
Completion date
2012-10-31
Last updated
2015-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children, Under-nutrition

Brief summary

This study will assess compliance with dietary recommendations, in conjunction with a nutritional supplement to meet the nutritional requirements in children and the effects of the compliance on promoting growth in children who are at risk of under-nutrition.

Detailed description

This study will assess compliance with dietary recommendations, in conjunction with an oral nutritional supplement to meet the nutritional requirements in children older than 36 (\>36) to less than or equal 48 (≤48) months of age, and the effects of the compliance on promoting catch-up growth and normal healthy growth in children who are at risk of under-nutrition.

Interventions

OTHERnutritional supplement

2 servings per day

Sponsors

Abbott Nutrition
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
36 Months to 48 Months
Healthy volunteers
Yes

Inclusion criteria

* Child is between 36 and 48 months of age. * Child has weight-for-height greater than or equal to 5th and less than or equal to the 25th percentile. * Child is capable of oral feeding. * Child's parent(s)or Legal Guardian is willing to abstain from giving additional non-study nutritional supplements to the child throughout the study period.

Exclusion criteria

* Child whose either parent has BMI greater than or equal to 27.5 kg/m2. * Child allergic or intolerant to any ingredient found in the study product. * Child who was delivered pre-term. * Child was born small for gestational * Child had birth weight \< 2500 g or \> 4000 g. * Child has current acute or chronic infections. * Child demonstrates presence of severe gastrointestinal disorders. * Child has a diagnosis of neoplastic diseases, renal, hepatic and cardiovascular diseases. * Child has a diagnosis of hormonal or metabolic disorders. * Child has a congenital disease or genetic disorder. * Child is diagnosed with infantile anorexia nervosa. * Child has a developmental disability or physical disorder. * Child has disorders of hemoglobin structure, function or synthesis. * Child is participating in another study that has not been approved as a concomitant study.

Design outcomes

Primary

MeasureTime frame
Compliance with recommendation of a nutritional supplement consumption48 weeks

Countries

Philippines

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026